The proposed sale is small in dollar value and by a director, not the CEO or CFO, so it carries limited signaling weight. Monitor for actual execution on Form 4; if the sale is completed, it may indicate routine portfolio diversification rather than negative conviction.
Price Chart
Executive Summary
Director Donald DeGolyer filed a Form 144 notice of intent to sell 17,800 common shares of Emergent BioSolutions Inc., with an estimated aggregate market value of approximately $126,120. The shares were acquired as restricted stock on October 2, 2026, and the sale is planned for execution on or after October 7, 2026. This is a relatively small sale relative to the company's market cap and the director's likely holdings, and no material financial data or company context is provided in the filing.
Key Facts
- Director Donald DeGolyer filed Form 144 to sell 17,800 shares of common stock.
- Estimated aggregate market value of the proposed sale is $126,120.12.
- Shares were acquired as restricted stock on October 2, 2026.
- Sale is planned for execution on or after October 7, 2026.
- The filing does not include any company financial data or guidance.
Financial Impact
Proposed sale of 17,800 shares valued at approximately $126,120, a small fraction of the company's market cap.
Risk Factors
- Insider sale intent could signal reduced confidence if followed by additional filings from other officers.
- No company financial context is provided in the filing, limiting assessment of timing relative to earnings or catalysts.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010097 |
| Document: 0001950047-26-010097-index.html | 0001950047-26-010097 |
| Document: 0001950047-26-010097.txt | 0001950047-26-010097 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 13d ago | 8-K | $6.38 $6.23 | ▼ −2.35% | ▼ −2.44% | $7.05 (+10.43%) |
Oct 7, 2026 21d ago | 144 | $6.81 $7.18 | ▲ +5.43% | ▲ +5.71% | $7.05 (+3.45%) |
Jun 29, 2026 17w ago | 8-K | $8.46 $8.18 | ▼ −3.31% | ▼ −4.70% | $7.05 (−16.72%) |
Jun 4, 2026 21w ago | Press Release | $8.44 $8.39 | ▼ −0.59% | ▲ +1.96% | $7.05 (−16.53%) |
Apr 30, 2026 25w ago | Press Release | $8.47 $9.13 | ▲ +7.79% | ▲ +5.45% | $7.05 (−16.82%) |
Apr 30, 2026 26w ago | Insider Cluster | $8.23 $9.10 | ▲ +10.57% | ▲ +8.84% | $7.05 (−14.40%) |
Apr 29, 2026 26w ago | Press Release | $7.99 $9.10 | ▲ +13.89% | ▲ +10.78% | $7.05 (−11.82%) |
Apr 29, 2026 26w ago | Press Release | $7.99 $9.10 | ▲ +13.89% | ▲ +10.78% | $7.05 (−11.82%) |
Apr 28, 2026 26w ago | DEFA14A | $8.23 $8.54 | ▲ +3.77% | ▲ +2.07% | $7.05 (−14.40%) |
Apr 28, 2026 26w ago | Press Release | $8.23 $8.54 | ▲ +3.77% | ▲ +2.07% | $7.05 (−14.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers